In a recent report, the National Task Group on Intellectual Disabilities and Dementia Practices (NTG)…
Kate O’NeillOctober 17, 2022
September 16, 2022 Research recently published in the journal Science (Manfredi-Lozano et al., Science 377,…
Kate O’NeillSeptember 16, 2022
In July 2022, John Cronin and his parents invited LuMind IDSC to follow their family…
Kate O’NeillSeptember 7, 2022
AN EXPLAINER FOR THE DOWN SYNDROME COMMUNITY April 15, 2022 BACKGROUND On April 7,…
adminApril 19, 2022
Institutions: Division of Medical Genetics and Metabolism at Massachusetts General Hospital, LuMind IDSC Foundation, the Department…
adminMarch 3, 2022
EXAMINING ADULTS WITH NEUROATYPICAL CONDITIONS FOR MCI/DEMENTIA DURING COGNITIVE IMPAIRMENT ASSESSMENTS: REPORT OF THE NEUROATYPICAL…
adminFebruary 18, 2022
January 26, 2022 In a study funded by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an…
adminJanuary 26, 2022
January 25, 2022 Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies…
adminJanuary 25, 2022
Impaired immune function is a clear and growing threat to the health and well-being of…
adminJanuary 20, 2022